Nadia Warner

1.5k total citations
28 papers, 1.2k citations indexed

About

Nadia Warner is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Nadia Warner has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 22 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Nadia Warner's work include Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (10 papers). Nadia Warner is often cited by papers focused on Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (10 papers). Nadia Warner collaborates with scholars based in Australia, United States and China. Nadia Warner's co-authors include Stephen Locarnini, Angeline Bartholomeusz, Stephen Locarnini, Lilly Yuen, Steven M. LeVine, P. Angus, Linda Discotto, William Sievert, A. Ayres and Kevin A. Pokornowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Hepatology.

In The Last Decade

Nadia Warner

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Warner Australia 15 1.0k 933 238 109 98 28 1.2k
Zhanhui Wang China 19 778 0.8× 696 0.7× 90 0.4× 110 1.0× 125 1.3× 58 998
Fanny Lebossé France 14 720 0.7× 757 0.8× 164 0.7× 103 0.9× 137 1.4× 37 1.0k
Sayuki Iijima Japan 15 445 0.4× 390 0.4× 162 0.7× 184 1.7× 226 2.3× 23 763
Laura Heydmann France 14 414 0.4× 383 0.4× 114 0.5× 106 1.0× 163 1.7× 24 635
S. Süsser Germany 21 1.2k 1.1× 1.4k 1.5× 448 1.9× 278 2.6× 78 0.8× 61 1.7k
Matthieu Blanchet Canada 12 447 0.4× 379 0.4× 80 0.3× 72 0.7× 58 0.6× 19 550
Marie–Sophie Hiet Germany 7 430 0.4× 532 0.6× 66 0.3× 159 1.5× 84 0.9× 8 697
Chunkyu Ko Germany 17 561 0.5× 398 0.4× 140 0.6× 261 2.4× 92 0.9× 27 758
Thekla Kemper Germany 15 602 0.6× 354 0.4× 135 0.6× 159 1.5× 173 1.8× 23 729
Stephanie K. Ladner United States 5 723 0.7× 554 0.6× 221 0.9× 161 1.5× 59 0.6× 7 792

Countries citing papers authored by Nadia Warner

Since Specialization
Citations

This map shows the geographic impact of Nadia Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Warner more than expected).

Fields of papers citing papers by Nadia Warner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Warner. The network helps show where Nadia Warner may publish in the future.

Co-authorship network of co-authors of Nadia Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Warner. A scholar is included among the top collaborators of Nadia Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Warner. Nadia Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Audsley, Jennifer, Anchalee Avihingsanon, Xin Li, et al.. (2025). Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection. Clinical Infectious Diseases. 82(1). e176–e184. 1 indexed citations
2.
Mountford, Simon J., Maki Kiso, Danielle E. Anderson, et al.. (2025). Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus. Communications Medicine. 5(1). 140–140. 5 indexed citations
3.
Xu, Hui, Stephen Locarnini, Darren Wong, et al.. (2021). Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A. Journal of Hepatology. 76(1). 34–45. 21 indexed citations
4.
Lim, Chun Shen, Vitina Sozzi, Margaret Littlejohn, et al.. (2021). Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes. Microbial Genomics. 7(1). 20 indexed citations
5.
Flanagan, Dustin J., Gregor Ebert, Nadia Warner, et al.. (2020). The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling. Cancers. 12(6). 1435–1435. 15 indexed citations
6.
Tschida, Barbara R., Tung-Ting Sham, Branden S. Moriarity, et al.. (2019). HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism. Molecular Cancer Research. 17(7). 1582–1593. 27 indexed citations
7.
Tolstrup, Martin, Kumar Visvanathan, Ian Woolley, et al.. (2018). Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine. Human Vaccines & Immunotherapeutics. 14(6). 1483–1488. 6 indexed citations
8.
9.
Ebert, Gregor, Simon Preston, Cody C. Allison, et al.. (2015). Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proceedings of the National Academy of Sciences. 112(18). 5797–5802. 75 indexed citations
10.
Warner, Nadia & Stephen Locarnini. (2014). Mechanisms of Hepatitis B Virus Resistance Development. Intervirology. 57(3-4). 218–224. 18 indexed citations
11.
Vincan, Elizabeth, et al.. (2012). HBV-related Hepatocellular Carcinoma: The Role of Integration, Viral Proteins and miRNA. Future Virology. 7(12). 1237–1249. 2 indexed citations
12.
Li, Wenpeng, Nadia Warner, Vitina Sozzi, et al.. (2012). Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype. Hepatology International. 7(2). 443–450. 10 indexed citations
13.
Shaw, Timothy J., Margaret Littlejohn, Danni Colledge, et al.. (2012). In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection. Journal of Medical Virology. 84(8). 1166–1176. 10 indexed citations
14.
Yuen, Lilly, et al.. (2011). Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits. Antiviral Research. 93(2). 209–218. 11 indexed citations
15.
Wilson, Robert, Nadia Warner, Kathleen E. Ryan, et al.. (2011). The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes. Journal of Viral Hepatitis. 18(10). e499–e507. 31 indexed citations
16.
Warner, Nadia & Stephen Locarnini. (2009). Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?. PubMed. 14(2). 139–42. 9 indexed citations
17.
Warner, Nadia & Stephen Locarnini. (2009). Article Commentary: Can Antiviral Therapy for Chronic Hepatitis B Enhance the Progression to Hepatocellular Carcinoma?. Antiviral Therapy. 14(2). 139–142. 9 indexed citations
18.
19.
Warner, Nadia, Stephen Locarnini, Michael J. Kuiper, et al.. (2007). The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro. Antimicrobial Agents and Chemotherapy. 51(7). 2285–2292. 83 indexed citations
20.
Bartholomeusz, Angeline, Michael J. Kuiper, P. Angus, et al.. (2006). 482 Molecular analysis of HBV polymerase mutations associated with dual adefovir and lamivudine resistance. Journal of Hepatology. 44. S179–S179. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhanhui Wang Breakdown of academic impact, for papers by Fanny Lebossé Breakdown of academic impact, for papers by Sayuki Iijima Breakdown of academic impact, for papers by Laura Heydmann Breakdown of academic impact, for papers by S. Süsser Breakdown of academic impact, for papers by Matthieu Blanchet Breakdown of academic impact, for papers by Marie–Sophie Hiet Breakdown of academic impact, for papers by Chunkyu Ko Breakdown of academic impact, for papers by Thekla Kemper Breakdown of academic impact, for papers by Stephanie K. Ladner
Rankless by CCL
2026